Helga S. Marques

2.3k total citations
31 papers, 1.4k citations indexed

About

Helga S. Marques is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Helga S. Marques has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Helga S. Marques's work include MRI in cancer diagnosis (13 papers), Radiomics and Machine Learning in Medical Imaging (12 papers) and AI in cancer detection (6 papers). Helga S. Marques is often cited by papers focused on MRI in cancer diagnosis (13 papers), Radiomics and Machine Learning in Medical Imaging (12 papers) and AI in cancer detection (6 papers). Helga S. Marques collaborates with scholars based in United States, Canada and United Kingdom. Helga S. Marques's co-authors include Etta D. Pisano, Nola M. Hylton, Mark Rosen, Laura J. Esserman, Wanda K. Bernreuter, Paul T. Weatherall, Constance D. Lehman, Gillian M. Newstead, Mitchell D. Schnall and Elizabeth A. Morris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Radiology.

In The Last Decade

Helga S. Marques

31 papers receiving 1.4k citations

Peers

Countries citing papers authored by Helga S. Marques

Since Specialization

Citations

This map shows the geographic impact of Helga S. Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga S. Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga S. Marques more than expected).

Fields of papers citing papers by Helga S. Marques

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga S. Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga S. Marques. The network helps show where Helga S. Marques may publish in the future.

Co-authorship network of co-authors of Helga S. Marques

This figure shows the co-authorship network connecting the top 25 collaborators of Helga S. Marques. A scholar is included among the top collaborators of Helga S. Marques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helga S. Marques. Helga S. Marques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181 2024 ·Blood ·Nina D. Wagner‐Johnston, Opeyemi A. Jegede, Stephen E. Spurgeon, Kami J. Maddocks, David T. Yang, Justin Romanoff, Jonas Paludo, Paolo F. Caimi, Nancy L. Bartlett, Patrick M. Reagan, Yazeed Sawalha, Marc Hoffmann, Boyu Hu, (unknown), Helga S. Marques, Lisa B. E. Shields, John P. Leonard, Jonathan W. Friedberg, Brad S. Kahl	2
2	Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112 2023 ·Journal of the National Comprehensive Cancer Network ·Tarah J. Ballinger, Helga S. Marques, (unknown), Richard L. Hoffman, Constantine Gatsonis, Fengmin Zhao, Kathy D. Miller, Joseph A. Sparano, Roisín M. Connolly	4
3	The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients 2023 ·Journal of Geriatric Oncology ·Efrat Dotan, Paul J. Catalano, Leon Lenchik, Robert D. Boutin, Xin Yao, Helga S. Marques, (unknown), David B. Zhen, Daneng Li, Lynne I. Wagner, Melissa A. Simon, Terence Z. Wong, Peter J. O’Dwyer	11
4	Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial 2022 ·Tomography ·Savannah C. Partridge, Jon A. Steingrimsson, David C. Newitt, Jessica Gibbs, Helga S. Marques, Patrick J. Bolan, Michael A. Boss, Thomas L. Chenevert, Mark Rosen, Nola M. Hylton	7
5	A simple assessment of lung nodule location for reduction in unnecessary invasive procedures 2021 ·Journal of Thoracic Disease ·C. Matthew Kinsey, Ehab Billatos, (unknown), (unknown), Bernard F. Cole, Fenghai Duan, Helga S. Marques, (unknown), Jorge Onieva Onieva, R. San José Estépar, (unknown), (unknown), (unknown), Jason H. T. Bates, Denise R. Aberle, Avi Spira, George R. Washko, Raúl San Jośe Estépar	1
6	Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial 2020 ·Tomography ·David C. Newitt, (unknown), Savannah C. Partridge, Helga S. Marques, B. Herman, Brian D. Ross, Nola M. Hylton, Thomas L. Chenevert, Dariya Malyarenko	11
7	Detection of early lung cancer among military personnel (DECAMP) consortium: study protocols 2019 ·BMC Pulmonary Medicine ·(unknown), Ehab Billatos, Fenghai Duan, Elizabeth Moses, Helga S. Marques, Irene Mahon, (unknown), Charles Apgar, Denise R. Aberle, George R. Washko, Avrum Spira	15
8	Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial 2018 ·Radiology ·Savannah C. Partridge, Zheng Zhang, David C. Newitt, Jessica Gibbs, Thomas L. Chenevert, Mark Rosen, Patrick J. Bolan, Helga S. Marques, Justin Romanoff, Lisa Cimino, Bonnie N. Joe, Heidi Umphrey, Haydee Ojeda‐Fournier, Başak E. Doğan, Karen Y. Oh, Hiroyuki Abé, Jennifer S. Drukteinis, Laura J. Esserman, Nola M. Hylton, (unknown)	187
9	Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686 2018 ·Neuro-Oncology ·Jerrold L. Boxerman, Zheng Zhang, Yair Safriel, Jeffrey M. Rogg, Ronald L. Wolf, Suyash Mohan, Helga S. Marques, A. Gregory Sorensen, Mark R. Gilbert, Daniel P. Barboriak	23
10	Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial 2018 ·Journal of Magnetic Resonance Imaging ·David C. Newitt, Zheng Zhang, Jessica Gibbs, Savannah C. Partridge, Thomas L. Chenevert, Mark Rosen, Patrick J. Bolan, Helga S. Marques, Sheye O. Aliu, Wen Li, Lisa Cimino, Bonnie N. Joe, Heidi Umphrey, Haydee Ojeda‐Fournier, Başak E. Doğan, Karen Y. Oh, Hiroyuki Abé, Jennifer S. Drukteinis, Laura J. Esserman, Nola M. Hylton, (unknown)	72
11	CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study 2017 ·Clinical Cancer Research ·Chaan S. Ng, Zheng Zhang, Susanna I. Lee, Helga S. Marques, (unknown), Feng Su, (unknown), Robert S. Mannel, Joan L. Walker, Warner K. Huh, Stephen C. Rubin, Paul DiSilvestro, Lainie P. Martin, John K. Chan, Michael A. Bookman, Robert L. Coleman, Ting-Yim Lee	20
12	Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial 2016 ·Gynecologic Oncology ·Mostafa Atri, Zheng Zhang, Farrokh Dehdashti, Susanna I. Lee, Shamshad Ali, Helga S. Marques, Wui-Jin Koh, Kathleen N. Moore, Lisa M. Landrum, Jae‐Weon Kim, Paul DiSilvestro, Eric Eisenhauer, Frederick M. Schnell, Michael A. Gold	66
13	Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL 2015 ·Radiology ·Nola M. Hylton, Constantine Gatsonis, Mark Rosen, Constance D. Lehman, David C. Newitt, Savannah C. Partridge, Wanda K. Bernreuter, Etta D. Pisano, Elizabeth A. Morris, Paul T. Weatherall, (unknown), Gillian M. Newstead, Helga S. Marques, Laura J. Esserman, Mitchell D. Schnall, (unknown)	186
14	Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma 2015 ·International Journal of Oncology ·Benjamin M. Ellingson, Eun Hee Kim, Davis C. Woodworth, Helga S. Marques, Jerrold L. Boxerman, Yair Safriel, Robert C. McKinstry, Felix Bokstein, Rajan Jain, Tom Chi, A. Gregory Sorensen, Mark R. Gilbert, Daniel P. Barboriak	46
15	Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233 2014 ·European Journal of Radiology Open ·Mostafa Atri, Zheng Zhang, Helga S. Marques, Jeremy Gorelick, Mukesh G. Harisinghani, Aslam Sohaib, Dow‐Mu Koh, Steven S. Raman, Michael S. Gee, Haesun Choi, Lisa M. Landrum, Robert S. Mannel, Linus Chuang, Jian Q. Yu, Carolyn K. McCourt, Michael A. Gold	10
16	Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL 2012 ·Radiology ·Nola M. Hylton, Jeffrey D. Blume, Wanda K. Bernreuter, Etta D. Pisano, Mark Rosen, Elizabeth A. Morris, Paul T. Weatherall, Constance D. Lehman, Gillian M. Newstead, (unknown), Helga S. Marques, Laura J. Esserman, Mitchell D. Schnall	359
17	Cystic Breast Masses and the ACRIN 6666 Experience 2010 ·Radiologic Clinics of North America ·Wendie A. Berg, (unknown), Helga S. Marques, Zheng Zhang	104
18	Comparison of Soft-copy and Hard-copy Reading for Full-Field Digital Mammography 2009 ·Radiology ·Robert M. Nishikawa, Suddhasatta Acharyya, Constantine Gatsonis, Etta D. Pisano, Elodia B. Cole, Helga S. Marques, Carl J. D’Orsi, Dione M. Farria, Kalpana M. Kanal, Mary C. Mahoney, Murray Rebner, (unknown)	14
19	Cancer Cases from ACRIN Digital Mammographic Imaging Screening Trial: Radiologist Analysis with Use of a Logistic Regression Model 2009 ·Radiology ·Etta D. Pisano, Suddhasatta Acharyya, Elodia B. Cole, Helga S. Marques, Martin J. Yaffe, Meridith Blevins, Emily F. Conant, R. Edward Hendrick, Janet K. Baum, Laurie L. Fajardo, Roberta A. Jong, Marcia Koomen, Cherie M. Kuzmiak, (unknown), Dag Pavić, Sora C. Yoon, (unknown), Constantine Gatsonis	16
20	Issues to Consider in Converting to Digital Mammography 2007 ·Radiologic Clinics of North America ·Etta D. Pisano, Margarita L. Zuley, Janet K. Baum, Helga S. Marques	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact